179 related articles for article (PubMed ID: 17085340)
1. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma.
Wang Y; Jin XQ; Wang S; Wang Q; Luo Q; Luo XJ
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):545-51. PubMed ID: 17085340
[TBL] [Abstract][Full Text] [Related]
2. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo.
Guo CB; Li YC; Jin XQ
Cancer Chemother Pharmacol; 2006 Jul; 58(1):40-9. PubMed ID: 16284790
[TBL] [Abstract][Full Text] [Related]
3. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
4. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
5. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
6. Transfer of the MDR1 (multidrug resistance) gene: protection of hematopoietic cells from cytotoxic chemotherapy, and selection of transduced cells in vivo.
Licht T; Gottesman MM; Pastan I
Cytokines Mol Ther; 1995 Mar; 1(1):11-20. PubMed ID: 9384659
[TBL] [Abstract][Full Text] [Related]
7. [Protection of hematopoietic cells against toxicity of anticancer agents by transfecting mdr1 gene into bone marrow cells].
Chen L; Liu Y
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):456-9. PubMed ID: 11235562
[TBL] [Abstract][Full Text] [Related]
8. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells.
Han LY; Ye MZ; Li YP; Wang BW; Wang Q; Zhao SH; Li HL
Chin Med J (Engl); 2008 May; 121(9):800-5. PubMed ID: 18701045
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
Hanania EG; Deisseroth AB
Clin Cancer Res; 1997 Feb; 3(2):281-6. PubMed ID: 9815684
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
[TBL] [Abstract][Full Text] [Related]
11. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo.
Buss EC; Laufs S; Naundorf S; Kuehlcke K; Nagy KZ; Zeller WJ; Fruehauf S
Cytotherapy; 2006; 8(6):562-9. PubMed ID: 17148033
[TBL] [Abstract][Full Text] [Related]
12. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Gan To Kagaku Ryoho; 1999 Jan; 26(1):1-9. PubMed ID: 9987494
[TBL] [Abstract][Full Text] [Related]
13. [Chemoprotection of transfer of multidrug resistance gene into human hematopoietic progenitor cell].
Pan L; Tong Y; Zhou S; Wu Y; Mao N; Yang X
Chin Med J (Engl); 2000 Jun; 113(6):536-9. PubMed ID: 11775875
[TBL] [Abstract][Full Text] [Related]
14. Transduction of mesenchymal stem cells with multidrug resistance gene provides protection for bone marrow toxicity after being transplanted into a nude mice model.
Han LY; Li YP; Ye MZ; Wang BW; Wang Q; Zhao SH; Li HL
Chin Med J (Engl); 2012 Sep; 125(18):3246-50. PubMed ID: 22964317
[TBL] [Abstract][Full Text] [Related]
15. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice.
Licht T; Goldenberg SK; Vieira WD; Gottesman MM; Pastan I
Gene Ther; 2000 Feb; 7(4):348-58. PubMed ID: 10694816
[TBL] [Abstract][Full Text] [Related]
16. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
17. Mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors.
Walther W; Stein U; Fichtner I; Alexander M; Shoemaker RH; Schlag PM
Cancer Gene Ther; 2000 Jun; 7(6):893-900. PubMed ID: 10880020
[TBL] [Abstract][Full Text] [Related]
18. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity.
Aksentijevich I; Cardarelli CO; Pastan I; Gottesman MM
Clin Cancer Res; 1996 Jun; 2(6):973-80. PubMed ID: 9816258
[TBL] [Abstract][Full Text] [Related]
19. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
Yagüe E; Higgins CF; Raguz S
Gene Ther; 2004 Jul; 11(14):1170-4. PubMed ID: 15164094
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]